Anti - β2 - glycoprotein i antibodies are highly pre valent in a large number of brazilian leprosy patients

Acta Reumatologica Portuguesa

Volumn 36, Issue 1, 2011, Pages 30-37

  Ribeiro, Sandra L E ^a,b   Pereira, Helena L A ^a,b   Silva, Neusa P ^b   Souza, Alexandre W S ^b   Sato, Emilia I ^b  

^a Rheumatology Division of Universidade Federal   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Anti 2 glycoprotein I antibodies; Anticardiolipin antibodies; Antiphospholipid antibodies; Antiphospholipid syndrome; Leprosy

Indexed keywords

AUTOANTIBODY; BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY;

ADULT; ARTICLE; BLOOD; BRAZIL; FEMALE; HUMAN; IMMUNOLOGY; LEPROSY; MALE;

ADULT; ANTIBODIES, ANTICARDIOLIPIN; AUTOANTIBODIES; BETA 2-GLYCOPROTEIN I; BRAZIL; FEMALE; HUMANS; LEPROSY; MALE;

EID: 79955651146     PISSN: 0303464X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Asherson RA, Cervera R. Antiphospholipid antibo dies and infections. Ann Rheum Dis 2003; 62:388-393.
2. Leroy V, Arvieux J, Jacob MC et al. Prevalence and significance of anticardiolipin, anti-ß2 glycoprotein I and anti-prothrombin antibodies in chronic hepatitis C. Br J Haematol 1998; 101:468-474.
3. de Larrañaga GF, Forastiero RR, Martinuzzo ME et al. High prevalence of antiphospholipid antibodies in leprosy: evaluation of antigen reactivity. Lupus 2000; 9:594-600.
4. Loizou S, Singh S, Wypkema E et al. Anticardiolipin, anti-beta(2)-glycoprotein I and antiprothrombin antibodies in black South African patients with infectious disease. Ann Rheum Dis 2003;62:1106-1111.
5. Von Landenberg P, Lehmann HW, Knöll A et al. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection. Arthritis Rheum 2003; 48:1939-1947.
6. Roubey RA. Immunology of the antiphospholipid antibody syndrome. Arthritis Rheum 1996;39:1444-1454.
7. Carreras LO, Forastiero RR, Martinuzzo ME. Which are the best biological markers of the antiphospholipid syndrome? J Autoimmun 2000;15:163-172.
8. Galli M, Comfurius P, Maassen C et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990;335:1544-1547.
9. Matsuura E. Igarashi Y, Fujimoto M, Ichikawa K et al. Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet 1990; 336:177-178.
10. McNeil HP, Simpson RJ, Chesterman CN et al. Antiphospholipid antibodies are direct against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta-2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 1990, 87:4120-4124.
11. Roubey RA, Eisenberg RA, Harper MF et al. 'Anticardiolipin' autoantibodies recognize beta 2-glycoprotein I in the absence of phospholipid. Importance of Ag density and bivalent binding. J Immunol 1995; 154:954-960.
12. McNally T, Purdy G, Machie IJ et al. The use of an anti-beta 2-glycoprotein-I assay for discrimination between anticardiolipin antibodies associated with infection and increased risk of thrombosis. Br J Haematol 1995; 91:471-473.
13. Martinuzzo ME, Forastiero RR, Carreras LO. Anti beta 2 glycoprotein I antibodies: detection and association with thrombosis. Br J Haematol 1995; 89:397-402.
14. Garcia-De La Torre I. Autoimune phenomena in leprosy, particularly antinuclear antibodies and rheumatoid factor. J Rheumatol 1993;20:900-903.
15. Thawani G, Bhatia VN, Mukherjee A. Anticardiolipin antibodies in leprosy. Indian J Lepr 1994;66:307-314.
16. Hojnik M, Gilburd B, Ziporen L et al. Anticardiolipin antibodies in infections are heterogeneous in their dependency on beta 2-glycoprotein I: analysis of anticardiolipin antibodies in leprosy. Lupus 1994; 3:515-521.
17. Bakos L, Correa CC, Bergmann L et al. Antiphospholipid antibodies thrombotic syndrome misdiagnosed as Lucio's phenomenon. Int J Lepr Other Mycobact Dis 1996;64:320-323.
18. Azulay-Abulafia L, Pereira Spinelli L, Hardmann D et al. Lucio-Phänomen Vaskulitis oder okklusive Vaskulopathie? Hautarzt 2006;57:1101-1105.
19. Furukawa F, Kashihara M, Imamura S et al. Evaluation of anti-cardiolipin antibody and its cross-reactivity in sera of patients with lepromatous leprosy. Arch Dermatol Res 1986; 278:317-319.
20. Fiallo P, Travaglino C, Nunzi E et al. Beta 2-glycoprotein I-dependence of anticardiolipin antibodies in multibacillary leprosy patients. Lepr Rev 1998; 69:376-381.
21. Elbeialy A, Strassburger-Lorna K, Atsumi T et al. Antiphospholipid antibodies in leprotic patients: a correlation with disease manifestations. Clin Exp Rheumatol 2000;18:492-494.
22. Repka JCD, Skare TL, Salles G Jr et al. Anticorpo anticardiolipina em pacientes com mal de Hansen. Rev Bras Reumatol 2001; 41(1): 1-6.
23. Arvieux J, Renaudineau Y, Mane I et al. Distinguishing features of anti-beta2 glicoprotein I antibodies between patients with leprosy and the antiphospholipid syndrome. Thromb Haemost 2002; 87:599-605.
24. Forastiero RR, Martinuzzo ME, de Larrañaga GF. Circulating levels of tissue factor and proinflammatory cytokines in patients with primary antiphospholipid syndrome or leprosy related antiphospholipid antibodies. Lupus 2005; 14:129-136.
25. Ridley DS, Jopling WH. Classification of Leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis 1966;34:255-273.
26. Souza AWS, Silva NP, Carvalho JP, D'Almeida V, Noguti MAE, Sato EI. Impact of hypertension and hyperhomocysteinemia on arterial thrombosis in primary antiphospholipid syndrome. Lupus 2007; 6:782-787.
27. Wilson WA, Gharavi AE, Koike T et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999; 42: 1309-1311.
28. Avcin T, Toplak N. Antiphospholipid antibodies in res ponse to infection. Curr Rheumatol Rep 2007; 9:212-218.
29. Shoenfeld Y, Blank M, Krause I. The relationship of antiphospholipid antibodies to infections-do they bind to infecting agents or may they even be induced by them? Clin Exp Rheumatol 2000; 18:431-432.
30. Blank M, Shoenfeld Y. Beta-2-glycoprotein-I, infections, antiphospholipid syndrome and therapeutic considerations. Clin Immunol 2004; 112:190-199.
31. Favaloro EJ, Silvestrini R. Assessing the usefulness of anticardiolipin antibody assays: a cautious approach is suggested by high variation and limited consensus in multilaboratory testing. Am J Clin Pathol 2002; 118:548-557.
32. Cabiedes J, Cabral AR, Alarcón-Segovia D. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein I than with antiphospholipid antibodies. J Rheumatol 1995; 22:1899-1906.
33. Detkova D, Gil-Aguado A, Lavilla P et al. Do antibodies to beta2-glycoprotein 1 contribute to the better characterization of the antiphospholipid syndrome? Lupus 1999; 8:430-438.
34. Forastiero RR, Martinuzzo ME, Cerrato GS et al. Relationship of anti beta2-glycoprotein I and anti prothrombin antibodies to thrombosis and pregnancy loss in patients with antiphospholipid antibodies. Thromb Haemost 1997; 78:1008-1014.
35. Cucurull E, Gharavi AE, Diri E et al. IgA anticardiolipin and anti-beta2-glycoprotein I are the most prevalent isotypes in African American patients with systemic lupus erythematosus. Am J Med Sci 1999; 318:55-60.
36. Lee EY, Lee CK, Lee TH et al. Does the anti-beta2-glycoprotein I antibody provide additional information in patients with thrombosis? Thromb Res 2003; 111:29-32.
37. Nash MJ, Camilleri RS, Kunka S et al. The anticardiolipin assay is required for sensitive screening for antiphospholipid antibodies. J Thromb Haemost 2004; 2:1077-1081.
38. Sanmarco M, Soler C, Christidies C et al. Prevalence and clinical significance isotype of IgG anti-beta2-glycoprotein I antibodies in antiphospholipid syndrome: a comparative study with anticardiolipina antibodies. J Lab Clin Med 1997; 129:449-506.
39. Voss A, Jacobsen S, Heegaard NH. Association of beta2-glycoprotein I IgG and IgM antibodies with thrombosis and thrombocytopenia. Lupus 2001; 10:533-538.
40. Horbach DA, van Oort E, Donders RC et al. Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Thromb Haemost 1996; 76:916-924.
41. Falcón CR, Martinuzzo ME, Forastiero RR et al. Pregnancy loss and autoantibodies against phospholipid-binding proteins. Obstet Gynecol 1997; 89:975-980.
42. Stern C, Chamley L, Hale L et al. Antibodies to beta 2 glycoprotein I are associated with in vitro fertilization implantation failure as well as recurrent miscarriage: results of a prevalence study. Fertil Steril 1998; 70: 938-944.
43. Teixidó M, Font J, Reverter JC et al. Anti-beta 2-glycoprotein I antibodies: a useful marker for the antiphospholipid syndrome. Br J Rheumatol 1997; 36:113-116.
44. Gharavi AE, Harris EN, Asherson RA et al. Anticardiolipin antibodies: isotype distribution and phospholipid specificity. Ann Rheum Dis 1987; 46:1-6.
45. de Laat B, Derksen RH, Urbanus RT et al. IgG antibodies that recognize epitope Gly40-Arg43 in domain I of beta 2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis. Blood 2005; 105:1540-1545.
46. Raschi E, Testoni C, Borghi MO et al. Endothelium activation in the anti-phospholipid syndrome. Biomed Pharmacother 2003; 57:282-286.
47. Forastiero RR, Martinuzzo ME, Carreras LO et al. Anti ß2 glicoprotein I antibodies and platelet activation in patients with antiphospholipid antibodies: association with increase excretion of platelet-derived thromboxane urinary metabolites. Thromb Haemost 1998; 79:42-45.
48. Martinuzzo ME, de Larrañaga GF, Forastiero RR et al. Markers of platelet, endothelial cell and blood coagulation activation in leprosy patients with antiphospholipid antibodies. Clin Exp Rheumatol 2002; 20:477-483.
49. Akerkar SM, Bichile LS. Leprosy & gangrene: a rare association; role of anti phospholipid antibodies. BMC Infect Dis 2005; 5:74.